Brief Report: Virologic Monitoring Can Be a Cost-Effective Strategy to Diagnose Treatment Failure on First-Line ART.
第一作者:
Alain M,Vandormael
第一单位:
*Genomics and Population Epidemiology Programme, Wellcome Trust Africa Centre for Population Health, University of KwaZulu-Natal, Durban, South Africa; †Department of Sociology, Minnesota Population Center, University of Minnesota, Minneapolis, MN; ‡Department of Medicine, Center for Infectious Disease and Microbiology Translational Research, University of Minnesota, Minneapolis, MN; §School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa; ‖Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA; and ¶Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.
作者:
主题词
成年人(Adult);抗HIV药(Anti-HIV Agents);CD4淋巴细胞计数(CD4 Lymphocyte Count);费用效益分析(Cost-Benefit Analysis);药费支出(Drug Costs);抗药性, 病毒(Drug Resistance, Viral);HIV感染(HIV Infections);人类(Humans);中年人(Middle Aged);敏感性与特异性(Sensitivity and Specificity);治疗失败(Treatment Failure);病毒载量(Viral Load)
DOI
10.1097/QAI.0000000000000870
PMID
26484740
发布时间
2020-09-30
- 浏览10
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文